Product category:
Nucleic acid sequencing and synthesis
News Release from: Bio-Rad Laboratories
Edited by the Laboratorytalk Editorial
Team on 18 October 2006
Bio-Rad buys Blackhawk BioSystems
Bio-Rad Laboratories has completed the acquisition of Blackhawk BioSystems, a manufacturer of quality control products for use in laboratories that perform infectious disease testing procedures
Founded in 1989, Blackhawk BioSystems is a privately held company whose product offerings include the complete line of Virotrol independent quality assurance reagents that are used along with commercially available testing procedures for hepatitis, HIV, sexually transmitted diseases (STDs), and a variety of other test procedures such as assays for congenital diseases, Epstein-Barr Virus (EBV), H.pylori, and Lyme With the acquisition of Blackhawk BioSystems infectious disease controls, Bio-Rad will be able to offer a broader line of quality control products for the clinical laboratory
This article was originally published on Laboratorytalk on 19 Feb 2002 at 8.00am (UK)
Related stories
Fully automated BSE testing system
New tests and automated platform promise to increase efficiency, produce faster results, expand mass screening capabilities, and reduce costs
"We are thrilled to have the opportunity to expand our quality control product offerings with Blackhawk BioSystems infectious disease controls," said Norman Schwartz, Bio-Rad president and CEO. Request free introductory details about products from Bio-Rad Laboratories ...
"Customers for these new controls will soon have the support of Bio-Rad's unique quality assurance software system, which offers customers online access to quality control data provided by thousands of laboratories worldwide for peer group interlaboratory comparison.".
• Bio-Rad Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
